Aging News & Blogs

-
How Hidden Markov Models Could Elucidate Multimorbidity in Aging
In a new study, researchers investigated longitudinal multimorbidity patterns among older adults from a Swedish urban population. … continue reading
-
Late-in-Life Interventions to Improve Cardiac Health
In a new research perspective, researchers discuss spermidine, rapamycin, caloric restriction, and exercise training to improve cardiac health in aging individuals. … continue reading
-
New Insights Into the Mechanisms of Sarcopenia
In this new study, researchers aimed to further elucidate the mechanisms of sarcopenia by examining the influence of denervation in young and middle-aged mice. … continue reading
-
Is Estrogen Dysregulation Behind Alzheimer’s Pathology?
In a new study, researchers explored Alzheimer’s disease and its potential relationship with the estrogen receptor-α gene (ESR1). … continue reading
Aging: Volume 15, Issue 2
-
Clearance of p16Ink4a-positive cells in a mouse transgenic model does not change β-cell mass and has limited effects on their proliferative capacity
Type 2 diabetes is partly characterized by decreased β-cell mass and function which have been linked to cellular senescence. Despite a low basal proliferative rate of adult β-cells, they can respond to growth stimuli, but this proliferative capacity decreases with age and correlates with increased expression of senescence effector, p16Ink4a.
Insights From Authors & Announcements
Aging | Clearance of p16Ink4a+ Cells: Limited Effects on B-Cell Mass and Proliferation in Mice
PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 15, Issue 2, entitled, “Clearance of p16Ink4a-positive cells in a mouse transgenic model does not change β-cell mass and has limited effects on their proliferative capacity.” https://doi.org/10.18632/aging.204483 The post Aging | Clearance of p16Ink4a+ Cells: Limited…
ABOUT AGING-US.ORG
Aging-US.org features weekly articles describing new and trending research papers published by Aging (Aging-US)—a twice-monthly, traditional, peer-reviewed journal with open access, covering all areas of research on aging, including age-related diseases, such as cancer.
The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases and prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.
Impact Journals, the publisher of Aging (Aging-US), meets the standards of the Wellcome Trust Publisher Requirements and was included in the Wellcome Trust List of Compliant Publishers. Read about our rigorous Scientific Integrity Process.
To learn more, please visit Aging-US.com and connect with us:
Facebook | Twitter | LinkedIn | YouTube | Instagram | Pinterest | SoundCloud